Interactive Virtual Presentations

Share

Program Content

Activities

  • Advanced UC: First-line Tx
    Selecting First-line Therapy for Advanced UC: Chemotherapy vs Immunotherapy
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 06, 2021

    Expires: May 05, 2022

  • Advanced UC: After Chemo and IO
    Treatment-Refractory Advanced Urothelial Cancer: What to Do After Chemotherapy and/or Immunotherapy
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 04, 2021

    Expires: May 03, 2022

  • Biomarkers in UC
    Individualized Patient Care: Role of Biomarkers in Urothelial Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 21, 2021

    Expires: April 20, 2022

  • IO in Localized UC
    Emerging Role for Immunotherapy in Localized Bladder Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 23, 2021

    Expires: April 22, 2022

  • Nurse Management of irAEs
    Managing Immune-Related Adverse Events: A Nursing Perspective
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 28, 2021

    Expires: May 27, 2022

  • UC Treatment: Patient View
    Dosing, Administration, and Risks/Benefits of Treatment Strategies for UC: A Patient’s Perspective
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 28, 2021

    Expires: May 27, 2022

Faculty

cover img faculity

Arjun Balar, MD

Associate Professor of Medicine
Perlmutter Cancer Center
NYU Langone Health
New York, New York

cover img faculity

Kaitlyn Francese, MSN, RN, OCN

Senior Nurse Clinician
Perlmutter Cancer Center
NYU Langone Health
New York, New York

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Pfizer and EMD Serono